ID   DPOE3_HUMAN             Reviewed;         147 AA.
AC   Q9NRF9; Q5W0U1; Q8N758; Q8NCE5; Q9NR32;
DT   30-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-MAY-2017, entry version 146.
DE   RecName: Full=DNA polymerase epsilon subunit 3;
DE            EC=2.7.7.7;
DE   AltName: Full=Arsenic-transactivated protein;
DE            Short=AsTP;
DE   AltName: Full=Chromatin accessibility complex 17 kDa protein;
DE            Short=CHRAC-17;
DE            Short=HuCHRAC17;
DE   AltName: Full=DNA polymerase II subunit 3;
DE   AltName: Full=DNA polymerase epsilon subunit p17;
GN   Name=POLE3; Synonyms=CHRAC17;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10880450; DOI=10.1093/emboj/19.13.3377;
RA   Poot R.A., Dellaire G., Huelsmann B.B., Grimaldi M.A., Corona D.F.V.,
RA   Becker P.B., Bickmore W.A., Varga-Weisz P.D.;
RT   "HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1
RT   and two novel histone-fold proteins.";
RL   EMBO J. 19:3377-3387(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 63-77 AND
RP   81-86, AND IDENTIFICATION IN EPSILON DNA POLYMERASE COMPLEX.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=10801849; DOI=10.1074/jbc.M002548200;
RA   Li Y., Pursell Z.F., Linn S.;
RT   "Identification and cloning of two histone fold motif-containing
RT   subunits of HeLa DNA polymerase epsilon.";
RL   J. Biol. Chem. 275:23247-23252(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Wu S.-H., Cheng J., Liu Y., Zheng Y.-J., Zhang Y.-X., Xie Q., Guo J.;
RT   "Screening and cloning of target genes differential expressed in HepG2
RT   cells treated with arsenic trioxide by suppression subtractive
RT   hybridization technique.";
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ALA-83 AND ASP-135.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-17 AND 40-58, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-83 AND SER-122, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
CC   -!- FUNCTION: Forms a complex with DNA polymerase epsilon subunit
CC       CHRAC1 and binds naked DNA, which is then incorporated into
CC       chromatin, aided by the nucleosome-remodeling activity of
CC       ISWI/SNF2H and ACF1.
CC   -!- CATALYTIC ACTIVITY: Deoxynucleoside triphosphate + DNA(n) =
CC       diphosphate + DNA(n+1).
CC   -!- SUBUNIT: Component of the epsilon DNA polymerase complex
CC       consisting of four subunits: POLE, POLE2, POLE3 and POLE4.
CC       Interaction with POLE4 is a prerequisite for further binding with
CC       POLE and POLE2. Interacts with CHRAC1. Together with CHRAC1, ACF1
CC       and ISWI/SNF2H proteins, it forms the ISWI chromatin-remodeling
CC       complex, CHRAC. {ECO:0000269|PubMed:10801849}.
CC   -!- INTERACTION:
CC       Q9NRG0:CHRAC1; NbExp=10; IntAct=EBI-744901, EBI-2795492;
CC       Q658N3:DKFZp666G145; NbExp=3; IntAct=EBI-744901, EBI-10240005;
CC       Q01658:DR1; NbExp=3; IntAct=EBI-744901, EBI-750300;
CC       Q14919:DRAP1; NbExp=6; IntAct=EBI-744901, EBI-712941;
CC       Q9Q2G4:ORF (xeno); NbExp=5; IntAct=EBI-744901, EBI-6248094;
CC       Q9NR33:POLE4; NbExp=7; IntAct=EBI-744901, EBI-867034;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested, including,
CC       heart, brain, placenta, lung, liver, skeletal muscle, kidney and
CC       pancreas.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pole3/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF226077; AAF72417.1; -; mRNA.
DR   EMBL; AF261689; AAF90133.1; -; Genomic_DNA.
DR   EMBL; AY720898; AAU15052.1; -; mRNA.
DR   EMBL; AK074629; BAC11099.1; -; mRNA.
DR   EMBL; AK074762; BAC11190.1; -; mRNA.
DR   EMBL; AK074782; BAC11206.1; -; mRNA.
DR   EMBL; DQ072116; AAY57326.1; -; Genomic_DNA.
DR   EMBL; AL137066; CAH70100.1; -; Genomic_DNA.
DR   EMBL; BC003166; AAH03166.1; -; mRNA.
DR   EMBL; BC004170; AAH04170.1; -; mRNA.
DR   CCDS; CCDS6795.1; -.
DR   RefSeq; NP_001265184.1; NM_001278255.1.
DR   RefSeq; NP_059139.3; NM_017443.4.
DR   UniGene; Hs.108112; -.
DR   ProteinModelPortal; Q9NRF9; -.
DR   SMR; Q9NRF9; -.
DR   BioGrid; 119903; 28.
DR   IntAct; Q9NRF9; 11.
DR   MINT; MINT-1439872; -.
DR   STRING; 9606.ENSP00000363284; -.
DR   DrugBank; DB00242; Cladribine.
DR   iPTMnet; Q9NRF9; -.
DR   PhosphoSitePlus; Q9NRF9; -.
DR   SwissPalm; Q9NRF9; -.
DR   BioMuta; POLE3; -.
DR   DMDM; 22653710; -.
DR   EPD; Q9NRF9; -.
DR   MaxQB; Q9NRF9; -.
DR   PaxDb; Q9NRF9; -.
DR   PeptideAtlas; Q9NRF9; -.
DR   PRIDE; Q9NRF9; -.
DR   TopDownProteomics; Q9NRF9; -.
DR   Ensembl; ENST00000374169; ENSP00000363284; ENSG00000148229.
DR   Ensembl; ENST00000374171; ENSP00000363286; ENSG00000148229.
DR   GeneID; 54107; -.
DR   KEGG; hsa:54107; -.
DR   UCSC; uc004bhn.4; human.
DR   CTD; 54107; -.
DR   DisGeNET; 54107; -.
DR   GeneCards; POLE3; -.
DR   HGNC; HGNC:13546; POLE3.
DR   HPA; HPA047945; -.
DR   MIM; 607267; gene.
DR   neXtProt; NX_Q9NRF9; -.
DR   OpenTargets; ENSG00000148229; -.
DR   PharmGKB; PA33499; -.
DR   eggNOG; KOG0870; Eukaryota.
DR   eggNOG; ENOG4111QSW; LUCA.
DR   GeneTree; ENSGT00550000074689; -.
DR   HOGENOM; HOG000007701; -.
DR   HOVERGEN; HBG060262; -.
DR   InParanoid; Q9NRF9; -.
DR   KO; K02326; -.
DR   OMA; NFAMKAK; -.
DR   OrthoDB; EOG091G0Y4D; -.
DR   PhylomeDB; Q9NRF9; -.
DR   TreeFam; TF103008; -.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-174430; Telomere C-strand synthesis initiation.
DR   Reactome; R-HSA-5651801; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-68952; DNA replication initiation.
DR   Reactome; R-HSA-68962; Activation of the pre-replicative complex.
DR   ChiTaRS; POLE3; human.
DR   GeneWiki; POLE3; -.
DR   GenomeRNAi; 54107; -.
DR   PRO; PR:Q9NRF9; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000148229; -.
DR   CleanEx; HS_POLE3; -.
DR   ExpressionAtlas; Q9NRF9; baseline and differential.
DR   Genevisible; Q9NRF9; HS.
DR   GO; GO:0005671; C:Ada2/Gcn5/Ada3 transcription activator complex; IDA:BHF-UCL.
DR   GO; GO:0008622; C:epsilon DNA polymerase complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; TAS:ProtInc.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; TAS:ProtInc.
DR   GO; GO:0006270; P:DNA replication initiation; TAS:Reactome.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0043966; P:histone H3 acetylation; IDA:BHF-UCL.
DR   GO; GO:0000722; P:telomere maintenance via recombination; TAS:Reactome.
DR   InterPro; IPR003958; CBFA_NFYB_domain.
DR   InterPro; IPR009072; Histone-fold.
DR   Pfam; PF00808; CBFD_NFYB_HMF; 1.
DR   SUPFAM; SSF47113; SSF47113; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Coiled coil; Complete proteome;
KW   Direct protein sequencing; DNA-binding; DNA-directed DNA polymerase;
KW   Nucleotidyltransferase; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.8}.
FT   CHAIN         2    147       DNA polymerase epsilon subunit 3.
FT                                /FTId=PRO_0000208341.
FT   COILED       85    146       {ECO:0000255}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES      83     83       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     122    122       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   VARIANT      83     83       T -> A (in dbSNP:rs36023979).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023464.
FT   VARIANT     126    126       D -> A (in dbSNP:rs34852828).
FT                                /FTId=VAR_057527.
FT   VARIANT     135    135       E -> D (in dbSNP:rs35933626).
FT                                {ECO:0000269|Ref.5}.
FT                                /FTId=VAR_023465.
FT   CONFLICT     58     58       K -> N (in Ref. 3; AAU15052 and 4;
FT                                BAC11206). {ECO:0000305}.
FT   CONFLICT     83     83       T -> I (in Ref. 4; BAC11190).
FT                                {ECO:0000305}.
FT   CONFLICT    146    146       D -> Y (in Ref. 2; AAF90133).
FT                                {ECO:0000305}.
SQ   SEQUENCE   147 AA;  16860 MW;  DC0A4D2097046569 CRC64;
     MAERPEDLNL PNAVITRIIK EALPDGVNIS KEARSAISRA ASVFVLYATS CANNFAMKGK
     RKTLNASDVL SAMEEMEFQR FVTPLKEALE AYRREQKGKK EASEQKKKDK DKKTDSEEQD
     KSRDEDNDED EERLEEEEQN EEEEVDN
//
